EMD Group Holding Inc. has received a federal tax lien notice from the Internal Revenue Service indicating it owes over $33.2 ...
If this CEO succeeds N-Power could save millions of dollars and lives in the fight against cancer. "The impact for cancer ...
The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by GlaxoSmithKline and Alphabet's Verily Life Sciences in 2016. A rheumatoid ...
SPARC Kips Bay is a win for public education, public health, and for the Kips Bay community. It’s an investment in a ...
Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...
GlobalData on MSN3d
New CEOs to join Merck KGaA’s executive boardJean-Charles Wirth and Danny Bar-Zohar are set to assume the life science and healthcare CEO roles respectively.
The New York City Council has approved two life sciences projects representing hundreds of millions of dollars in capital investment and thousands of new jobs, according to a press release issued by ...
The Philadelphia market has gained recognition not only for its cell and gene therapy sector but also its real estate scene and talent pool. Vittoria Biotherapeutics, Interius BioTherapeutics and ...
Mark Zuckerberg is taking a break from expanding the Metaverse to instead expand his real-world foundation’s footprint in ...
Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...
A new report says that London is the top city in Europe for the life sciences industry, and ranks third worldwide after Boston and New York in the US. That puts the city above some well-recognised ...
Radiance Biopharma is heating up the ROR1 race. The U.S. biotech is paying China’s CSPC Megalith Biopharmaceutical $15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback